Reali Kenneth Michael 4/A
4/A · Bioventus Inc. · Filed Apr 21, 2023
Insider Transaction Report
Form 4/AAmended
Reali Kenneth Michael
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-14+466,054→ 466,054 totalExercise: $1.16Exp: 2032-03-13→ Class A Common Stock (466,054 underlying)
Footnotes (1)
- [F1]The options shall vest in four approximately equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.